BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11012087)

  • 1. The ZF87/MAZ transcription factor functions as a growth suppressor in fibroblasts.
    Stubbs MC; Min I; Izzo MW; Rallapalli R; Derfoul A; Hall DJ
    Biochem Cell Biol; 2000; 78(4):477-85. PubMed ID: 11012087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal Alz-50 clone 1 (FAC1) protein interacts with the Myc-associated zinc finger protein (ZF87/MAZ) and alters its transcriptional activity.
    Jordan-Sciutto KL; Dragich JM; Caltagarone J; Hall DJ; Bowser R
    Biochemistry; 2000 Mar; 39(12):3206-15. PubMed ID: 10727212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional repression from the c-myc P2 promoter by the zinc finger protein ZF87/MAZ.
    Izzo MW; Strachan GD; Stubbs MC; Hall DJ
    J Biol Chem; 1999 Jul; 274(27):19498-506. PubMed ID: 10383467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
    Greider C; Chattopadhyay A; Parkhurst C; Yang E
    Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulation of specific E2F complexes by the v-mos oncogene.
    Afshari CA; Rhodes N; Paules RS; Mudryj M
    Oncogene; 1997 Jun; 14(25):3029-38. PubMed ID: 9223666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DNA-binding and transcriptional activities of MAZ, a myc-associated zinc finger protein, are regulated by casein kinase II.
    Tsutsui H; Geltinger C; Murata T; Itakura K; Wada T; Handa H; Yokoyama KK
    Biochem Biophys Res Commun; 1999 Aug; 262(1):198-205. PubMed ID: 10448092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
    Alevizopoulos K; Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity.
    Berns K; Hijmans EM; Bernards R
    Oncogene; 1997 Sep; 15(11):1347-56. PubMed ID: 9315103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of Myc-associated zinc finger protein with DCC, the product of a tumor-suppressor gene, during the neural differentiation of P19 EC cells.
    Ugai H; Li HO; Komatsu M; Tsutsui H; Song J; Shiga T; Fearon E; Murata T; Yokoyama KK
    Biochem Biophys Res Commun; 2001 Sep; 286(5):1087-97. PubMed ID: 11527412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Members of the MAZ family: a novel cDNA clone for MAZ from human pancreatic islet cells.
    Tsutsui H; Sakatsume O; Itakura K; Yokoyama KK
    Biochem Biophys Res Commun; 1996 Sep; 226(3):801-9. PubMed ID: 8831693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the C-myc promoter-binding factor zf87/pur1 in transformed and nontransformed cell-lines.
    Pyrc J; Logan T; Hall D
    Int J Oncol; 1994 Nov; 5(5):1085-91. PubMed ID: 21559684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM; Dickson RB
    Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF
    Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cell cycle duration by c-myc levels.
    Karn J; Watson JV; Lowe AD; Green SM; Vedeckis W
    Oncogene; 1989 Jun; 4(6):773-87. PubMed ID: 2660073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RACK1 regulates G1/S progression by suppressing Src kinase activity.
    Mamidipudi V; Zhang J; Lee KC; Cartwright CA
    Mol Cell Biol; 2004 Aug; 24(15):6788-98. PubMed ID: 15254245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF.
    Zhang HS; Gavin M; Dahiya A; Postigo AA; Ma D; Luo RX; Harbour JW; Dean DC
    Cell; 2000 Mar; 101(1):79-89. PubMed ID: 10778858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin A1, the alternative A-type cyclin, contributes to G1/S cell cycle progression in somatic cells.
    Ji P; Agrawal S; Diederichs S; Bäumer N; Becker A; Cauvet T; Kowski S; Beger C; Welte K; Berdel WE; Serve H; Müller-Tidow C
    Oncogene; 2005 Apr; 24(16):2739-44. PubMed ID: 15829981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression.
    Qi Y; Tu Y; Yang D; Chen Q; Xiao J; Chen Y; Fu J; Xiao X; Zhou Z
    J Cell Physiol; 2007 Jan; 210(1):63-71. PubMed ID: 17013808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.